Introduction
Non-steroidal anti-inflammatory drugs (NSAIDs) are a major cause of morbidity and mortality among users. Epidemiological data suggest that they increase the risk of ulcer complications and death by 3-10-fold. The pathogenesis of these serious events is unknown. NSAIDs 206 are one kind of the most frequently used drugs world wide [1] , aspirin is one of them. Cross-sectional studies indicate that gastric or duodenal ulcers are present in 10-25% of patients on long-term NSAIDs [2] . Furthermore, continuing usage of NSAIDs often results in the recurrence of gastric ulcer [3] .
Prostaglandin deficiency can impair the quality of ulcer healing (QOUH) [4] . Aspirin directly damages gastric mucosa [5] , decreases prostaglandin synthesis [6, 7] , inhibits ulcer contraction [8] and decreases gastric mucosal blood flow (GMBF) in the ulcer margin [9] . In the healed ulcer, the mucosal structure is in disorder, such as reduced thickness of regenerative mucosa, dilated gland tissue, reduced angiogenesis, and excessive hyperplasia of connective tissue [10] [11] [12] [13] . Therefore, gastric acid, prostaglandin, COX, GMBF and QOUH may affect the ulcer relapse.
The recurrent mechanism of peptic ulcer is still not clear [14] . We therefore established the gastric ulcer model in rats with acetic acid induction. Our hypothesis was that continuous aspirin administration can cause ulcer recurrence in acetic acid inducted ulcer model; the ulcer recurrence may be because of the increased aggressive factors and decreased protective factors due to aspirin usage. The monitored aggressive factors in this study include gastric secretion and its pH and protective factors include PGE 2 , COX-1, COX-2 and GMBF. Furthermore, the relationship between QOUH and aspirin administration was also evaluated.
Materials and Methods

Ulcer induction, aspirin induced recurrence and morphological observation
Male Wistar rats weighing 180-200 g were used in this study. Rats were fasted 24 hours before experiment with free access to drinking water. Experiments were divided into two steps: Firstly, gastric ulcer was induced according to the method previously reported [15] . Some of the rats with ulcers were killed on the test day (day 3, 15 or day 25) and ulcer area was measured with the method described previously [16] . Secondly, on day 25, the remains were randomly assigned to the following three groups: Fasting control group: rats were fasted for 5 hours per day from day 25 to day 54 and then rats were killed on day 55 to collect samples; Saline control group: fasting and sample collection procedure was the same as fasting control group, saline (4ml/kg/day) was given by gavage at the point of 4 hours fasting and continued for another hour fasting from day 25 to day 54; Aspirin group, all of the procedures are the same as saline control group the only difference was to substitute aspirin (40 mg/ kg/day, Sigma Chemical, St Louis, Missouri, USA) for saline.
Histology
Rat stomach was exposed. After observation of gastric ulcer, the specimen were collected, fixed and cut along gastric long axis and stained with haematoxylin and eosins (H-E). The slides were examined under microscope (Olympus, Tokyo, Japan).
Gastric secretion
In order to determine gastric secretion, the pylorus was ligated for 4 hours and then cardia part was also ligated, finally the stomach was cannulated to collect gastric contents which were centrifuged at 3,500 rpm/min for 10 min, the supernatant volume and pH (pH meter, PHS-25, Shanghai, China) were measured.
Gastric mucus, gastric mucosal blood flow (GMBF) and mucosal PGE 2 Gastric mucus was determined according to the previous method [17] with a slight modification. Briefly, stomach was cut along lesser curvature. Stomach was inside out, immersed in 20 ml Alcian blue buffer (8mg/100ml, buffer: 0.2M Na 2 HPO 4 , 0.1M citric acid, pH=5.8) and incubated for 2 hours. Then, 6ml of incubation liquid were collected and centrifuged at 3000 rpm/ min for 10 min. Optical density (OD) of the supernatant was determined at 615 nm wavelength. Result was expressed as a conjunctive dye quantity/20ml Alcian blue staining solution (mg/20ml).
GMBF was measured using hydrogen gas clearance technique [18] . The clearance curve of tissue hydrogen was used to calculate the volume of blood flow (ml/min/100g).
To determine PGE 2 , ulcer area was scraped with glass slides, weighed and put in a tube containing 100% ethanol plus 0.1 M indomethacin [19] . Then, gastric mucosa was homogenized and centrifuged for 10 min at 12,000 rpm/min and 4°C. PGE 2 content in supernatant was determined with enzyme immunoassay (Cayman Chemical, Ann Arbor, MI, USA), following manufacturer's instruction. PGE 2 concentration was expressed as ng /g tissue.
COX-1 and COX-2 mRNA expression quantified by RT-PCR
Total RNA from rat gastric ulcer tissue was extracted using Trizol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's protocol. First single-stranded cDNA was generated with 5 µg total RNA using ReverttAid 72°C for 1 min. The cycle number for β-actin was 30, for COX-1 and COX-2 were 35. PCR product was electrophoresed in 1.5% agarose gels containing 0.2µg/ml of ethidium bromide. The density of COX-1 or COX-2 is expressed in arbitrary densitometry units normalized to β-actin expression.
Tissues collected in gastric ulcer location were homogenized in lysis buffer containing 50 mM Tris-HCl (pH 7.4), 1% Nonidet (NP40), 150 mM NaCl and protease inhibitor cocktail, then, centrifuged at 12,000×g for 20 min. the supernatant was collected. Equal amounts (50µg) of the denatured proteins per lane were loaded and separated on sodium dodecyl sulfate-10% polyacrylamide gels by electrophoresis. Proteins were then transferred to PVDF membrane (BioRad Laboratories, Hercules, CA) by electroblotting. Blots were blocked at least one hour at room temperature with 0.4% I-Block (Tropix, Bedford, MA) in TBSTween-20 buffer (137 mmol NaCl, 20 mmol Tris-HCl, pH 7.4, 0.1% Tween-20). The membranes were washed with TBS-T (3 Fig. 1 times, 10 min each) and then incubated at room temperature for one hour with highly specific mouse monoclonal anti-COX-1 antibody (1:500, Santa Cruz, CA) or goat polyclonal anti-COX-2 antibody (1:200, Santa Cruz, CA) or mouse monoclonal anti-β-actin antibody (Sigma-Aldrich, St. Louis, MO). After 3 washes, the membranes were incubated with horseradish peroxidase-linked rabbit anti-mouse or rabbit anti-goat immunoglobin (1:2000) . Blots were detected with chemiluminescence (Applied Biosystems, Bedford, MA). The relative expression of COX-1 and COX-2 protein in different groups was quantified by computerized optical densitometric scanning of the images and β-actin band was used as internal control.
Evaluation of QOUH
QOUH was evaluated under light microscope. The inner diameter of gland cavity >8 µm (about 3 times of normal gland) was considered as dilated glands which were counted in regenerative mucosa. Result was expressed as dilated gland number/HP.
Statistical analysis
Results are expressed as mean ± SD. SPSS (Version 11.0) software was used. For analysis among groups, one-way ANOVA with least significant difference (LSD) or rank sum test with Mann-Whitney. The significance level was set at P < 0.05.
Results
Ulcer size and morphologic features
Ulcer area was 27±1.07 mm 2 , 3.13±1.13mm 2 and 0±0 mm 2 respectively on day 3, day 15 and day 25 following ulcer induction (Fig 1A, Fig 1B and Fig 1C) . Figure 1 showed us that 25 days later after acetic acid application, induced ulcer healed completely, however, the area contacted directly with acetic acid was pale. Continuous experiment demonstrated that on day 45, 2 rats showed ulcer relapse. This number increased to 5 after 10 more days continuous aspirin treatment (n=8); furthermore, there were bleeding points on the surface of mucosa (Fig 1F) . There is no ulcer recurrence in other two groups (Table1). Moreover, the pale area decreased on day 55 in these animals ( Fig 1D, Fig 1E) .
On day 25, although the ulcer was healed, the glands in acetic acid attacked area were dilated (Fig 2B) . On day 55, there are still dilated glands in ulcer area in fasting (Fig 2C) and saline control groups (Fig 2D) , In Aspirin group, 5 out of 8 rats with ulcer recurrence had a thin mucosa at ulcer margin (Fig 2E) , while there was no difference between aspirin treated but ulcer (Fig. 2F, n=3 ) rats and other animals (Fig 2A) .
The effects of aspirin on aggressive and protective factors
The gastric juice volume in aspirin group was significantly higher than those of fasting and saline control groups on day 55 (P<0.01, Fig 3A) , while the pH value of gastric juice in aspirin group was significantly lower than that of other two groups (P<0.01, Fig 3B) .
Gastric mucus, GMBF and mucosal PGE 2 concentration were all significantly decreased in aspirin group compared with other two groups (P<0.01, Fig 4A,  Fig 4B and Fig 4C) .
The effect of aspirin on COX-1 and COX-2 expression
Neither COX-1 mRNA transcription nor protein expression differed among all three groups. However, COX-2 mRNA transcription and protein expression were significantly increased in aspirin group compared with other two groups (P<0.01, Fig 5A, Fig 5B, Fig 5C) .
The effect of aspirin on QOUH
The number of dilated glands in aspirin treated group was significantly increased compared with fasting or saline control group (P<0.01, Fig 6) .
Discussion
Previous studies showed that aspirin induced gastric ulcer and delayed its healing [20] [21] [22] [23] . The present study showed that aspirin cause ulcer recurrence in healed ulcer area. Aspirin decreases GMBF and synthesis of gastric mucus and PGE 2 , increases gastric acid secretion, affects the quality of ulcer healing, and all of these factors together result in the ulcer recurrence. Acetic acid ulcer model resembles human ulcers in terms of both pathological features and healing process [24] . In the present study, the ulcerated area contracted gradually and ulcers healed completely in 25 days ( Fig  1A, Fig 1B and Fig 1C) . This study is consistent with the previous one [15] . On day 45 and 55, the healed ulcer area showed recurrence in aspirin group. In comparison, there is no ulcer relapse in fasting and saline control groups (Table.1 ).These results indicated that it is aspirin that caused the ulcer recurrence. It is well documented that gastric ulcers induced by acetic acid injection (0.05ml of 20%) into the submucosa can show up again on day 91 [25] . The end point of this study is 55 days, so it remains to be clarified whether ulcer relapse occur in fasting or saline control group after 55 day.
The treatment of peptic ulcer has been based mainly on inhibiting the secretion of gastric acid [26] . The present study showed that gastric juice was significantly higher in aspirin group than that in fasting or saline control group. While the pH value in aspirin group was significantly lower than that in other two groups. All of these results suggested that gastric acid was a pivotal factor in ulcer relapse.
Gastric mucus covers the surface of gastric epithelium and forms a layer of mucus barrier. This barrier constitutes the first line of defense that protects gastric mucosa from its own gastric juice. In the present study, the gastric mucus in aspirin group was significantly lower than those in other two groups. This result indicates that aspirin reduces the production of gastric mucus. Our result is consisted with other studies [27] [28] [29] and the gastric mucus deficiency may be involved in ulcer relapse in aspirin group. GMBF is also one of the important protective factors [30] . GMBF provides gastric epithelial cells with bicarbonate which neutralizes the acid diffused back to epithelial and thus maintains pH gradient in mucus layer [31, 32] . GMBF also provides oxygen and nutrient substances to gastric mucosa to support mucosal renewal. An adequate blood flow is important for the production of mucus and bicarbonate [33] . Classic NSAIDs can reduce GMBF [15] . Our study showed that GMBF was significantly lower in aspirin group than those in other two groups. Therefore, GMBF reduction is also a factor for ulcer recurrence. Another protective factor is PGE 2, PGE 2 is one of the major prostanoids in gastric tissue [34] . PGE 2 can inhibit gastric acid secretion [6] , our result demonstrated that PGE 2 was significantly decline in aspirin treated group. Thus, PGE 2 might indirectly take part in ulcer relapse via acid secretion.
Cyclooxygenase (COX), the key enzyme for synthesis of prostaglandins, exists in three isoforms COX-1, COX-2 and COX-3. COX-1 is a constitutive enzyme that expressed in gastrointestinal tract and has been suggested to maintain mucosal integrity through continuous generation of prostaglandins. COX-2 is an induced enzyme that expressed in large quantities during inflammation [35] . Administration of aspirin was accompanied by the suppression of COX-1 and COX-2 activity in the gastric mucosa [36] . Inhibition of prostaglandin synthesis probably weakened the function of the gastric mucosal defense [37] . The present study showed that COX-1 mRNA and protein were expressed in ulcer area on day 15 after ulcer induction as well as in the following three groups on day 55. COX-2, the induced isoform, its mRNA and protein was detectable in fasting and saline control groups on day 55, COX-2 mRNA transcription and protein expression were significantly induced in ulcer area tissue on day 15 after ulcer induction and on day 55 in aspirin group. It indicated that the increased expressions of COX-2 during ulceration and ulcer recurrence. These results indicated that aspirin can reduce the activities of COX-1 and COX-2 and thus, reduce PGE 2 concentration in mucosa, aspirin did not prohibit COX-1 and COX-2 synthesis.
Gastric cellular epithelia and tight junction among gastric cellular epithelia form a mucosal barrier. This mucosal barrier constitutes the second line of defense that protects the gastric mucosa from harmful factors. QOUH plays an important role in ulcer relapse. The deformed gastric mucosa weakens barrier function. The quantity of dilated glands was significantly increased in aspirin group compared with fasting and saline control ones, while the mucosal structure in no-recurrence animals was similar to that of the normal mucosa (Fig 2F, Fig  2A) . This indicates that aspirin can result in poor QOUH. In addition, aspirin elevates plasma proinflammatory cytokines such as TNF-α, which leads to leukocyte infiltration in the gastric mucosa [6] and thus, induces gastric ulcer relapse [38] .
In summary, the mechanism that aspirin causes ulcer recurrence may be: aspirin inhibit COX-1 and COX-2 activities, the consequence of this inhibition is to decrease PGE 2 synthesis, PGE 2 deficiency results in the increase of gastric acid secretion, decrease of GMBF and gastric mucus synthesis. The imbalanced protective and aggressive factors finally resulted in poor quality of ulcer healing and ulcer relapse. 
